Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum NeutriSci International Inc V.NU.H

Alternate Symbol(s):  NRXCF

NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the production, and formulation of nutraceutical products within the business-to-business (B2B) industry. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans... see more

TSXV:NU.H - Post Discussion

NeutriSci International Inc > Reviews are good from Germany
View:
Post by geodcan on Mar 15, 2023 2:52pm

Reviews are good from Germany

but none newer than 6 months which raises the question of whether we are availble, sold out, consumers loss of interest or other problems related to supply and sales.

More questions than answers and low volume suggests low interest in our sku from consumers and the shareprice suggests low interest from investors.

Long lasting malaise in cannabinoid investments and the possibility that this is hanging by a thread with no catalyst forthcoming by politicians in the US.

Nothing from our management team to suggest any kind of a plan or even solvency is concerning.

Sadly we have to face the possibility of self interested management with a deliberative plan to wind up with the spoils or that they just don't have an alternative plan.

I kind of think that Cryopharm was our inspiration but I am not sure of their viability and they are not publicly traded that I am aware of.

We could be in that 90% plus pot cos destined for failure and delisting, sadly after 10 years survival.

glta and dyodd
Comment by NEWBIE65 on Mar 16, 2023 4:50pm
Pretty sure Cryopharm was just a creation by NU to pretend there is another company interested in NU. They are only online as far as I can see. If they exist at all. My guess is they dont. and neither does anyting else. Smoke and mirrors
Comment by ThatBigGinger on Mar 20, 2023 10:52am
Cryopharm / neutrisci 's powdered thc product won an award in high times cannabis cup...ofcourse they exist 
Comment by Cdnguy81 on Mar 20, 2023 7:11pm
Really? WOW. That participation award is really helping that share price isn't it? Hey, I noticed the volume is 0 today.  Shouldn't you be busy buying more shares considering anything under .20 is a steal? I mean, when Cryopharm wins more participation awards there's no telling how high the price can go, why it could even go to .02! 
Comment by geodcan on Mar 21, 2023 2:20pm
I think this is called scratching for some news.  Probably an old nr or post of better days gone by. If this is current, pls post a link. This will probably go the way of a few others I plunked down on.  First a halt, probably for no reporting, then a suspension, then a delisting and it will continue to dwindle away on the pinks in the US because they don't honour those decisions ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities